Skip to content

Usefulness of Homoeopathy in the Treatment of urinary tract stones.

Effectiveness of Individualised Homoeopathic medicines in comparison with Berberis Vulgaris in the treatment of Urolithiasis: An open label prospective randomised clinical trial

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/08/056290
Enrollment
62
Registered
2023-08-08
Start date
Unknown
Completion date
Unknown
Last updated
2023-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N20-N23- Urolithiasis

Interventions

Intervention1: Individualised Homoeopathic Medicines: Intervention is planned as administering individualised Homoeopathic medicines in fifty millesimal potencies. Dosage- 30 doses, ODAC for 1month.Ro

Sponsors

none
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients diagnosed with urolithiasis (by radiological evidence: Ultrasonography of lower abdomen/K.U.B/C.T/M.R.I etc.) 2.Patients between 20-70 years of age, all religions, all socio-economic status. 3.All sexes, genders, races. 4.Patients who are on lifesaving conventional drug therapies (e,g antidiabetics, antihypertensives, thyroid drugs)to be continued uninterrupted. 6.Patients who are willing to give written consent to participate in the study.

Exclusion criteria

Exclusion criteria: 1. Diagnosed cases of unstable mental or psychiatric illness. 2.Patients who are suffering from any life-threatening illness or other uncontrolled systemic disease affecting quality of life or any other vital organ. 3.Patients who are suffering from any major complication, Congenital Anomalies of Kidney and the Urinary Tract, severe hydronephrosis. 4.Patients who are on active treatment from any other system of medicine. 5.Patients not willing to give consent for participation in the study. 6.Patients not willing to undergo any investigation if advised.

Design outcomes

Primary

MeasureTime frame
Primary outcome: Urolithiasis Symptom Score (USS score) On the basis of score obtained from USS index chart, cases according to intensity will be grouped into mild (1-7), moderate (8-14) and severe (15-22). The scores of the initial and follow ups will be compared.Timepoint: Baseline,3rd and 6th month of treatment

Secondary

MeasureTime frame
Ultrasonography of KUB region at baseline,3 rd and 6th month of treatment will be done to assess/compare the number, size and location of the calculus/calculi. Timepoint: Baseline,3rd and 6th month of treatment

Countries

India

Contacts

Public ContactChristina Lalhriatpuii

National Institute of Homoeopathy,Kolkata

drprasantarath09@gmail.com8420924836

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026